US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies(Delisted)

Watchlist
  • 131.870
  • 0.0000.00%
Close Apr 1 16:00 ET
14.05BMarket Cap-183.15P/E (TTM)

Intra-Cellular Therapies(Delisted) Key Stats

Intra-Cellular Therapies(Delisted) Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 225.449M--
--2025/Q1-- / 205.261M--
--2024/Q4199.223M / 193.286M--
Oct 30, 20242024/Q3175.375M / 172.353M--
Aug 7, 20242024/Q2161.388M / 157.884M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 225.449M--
--2025/Q1-- / 205.261M--
--2024/Q4199.223M / 193.286M--
Oct 30, 20242024/Q3175.375M / 172.353M--
Aug 7, 20242024/Q2161.388M / 157.884M--

Unlock Free Earnings Estimates

Intra-Cellular Therapies(Delisted) Earnings Reports

Read more

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.